ELAVL1 Modulates Transcriptome-wide miRNA Binding in Murine Macrophages

Cell Reports

Volumn 9, Issue 6, 2014, Pages 2330-2343

  Lu, Yi Chien ^a   Chang, Sung Hee ^a   Hafner, Markus ^b   Li, Xi ^a   Tuschl, Thomas ^b   Elemento, Olivier ^a   Hla, Timothy ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; ARGONAUTE 2 PROTEIN; CAVEOLIN; CHEMOKINE RECEPTOR CXCR4; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ELAVL1 PROTEIN; GUANOSINE TRIPHOSPHATASE; HEME OXYGENASE 1; HUR PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MICRORNA; MYC PROTEIN; MYOCYTE ENHANCER FACTOR 2; NEUROPILIN; PROTEIN BCL 2; RHO KINASE; RNA BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; TRANSCRIPTION FACTOR E2F7; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRISTETRAPROLIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; 3' UNTRANSLATED REGION; ELAV LIKE PROTEIN 1; ELAV PROTEIN; ELAVL1 PROTEIN, HUMAN; MIRN27 MICRORNA, MOUSE; ZFP36 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING SITE; BONE MARROW CELL; CHEMOTAXIS; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA SEQUENCE; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS;

MURINAE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; ELAV PROTEINS; ELAV-LIKE PROTEIN 1; HEK293 CELLS; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; TRANSCRIPTOME; TRISTETRAPROLIN;

EID: 84919862308     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.11.030     Document Type: Article

References (55)

1. Abdelmohsen K., Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA 2010, 1:214-229.
2. Abdelmohsen K., Lal A., Kim H.H., Gorospe M. Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 2007, 6:1288-1292.
3. Al-Ahmadi W., Al-Ghamdi M., Al-Haj L., Al-Saif M., Khabar K.S. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. Nucleic Acids Res. 2009, 37:3612-3624.
4. Bhandari A., Gordon W., Dizon D., Hopkin A.S., Gordon E., Yu Z., Andersen B. The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1. Oncogene 2013, 32:1497-1507.
5. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
6. Blackshear P.J., Lai W.S., Kennington E.A., Brewer G., Wilson G.M., Guan X., Zhou P. Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates. J.Biol. Chem. 2003, 278:19947-19955.
7. Boudreau R.L., Jiang P., Gilmore B.L., Spengler R.M., Tirabassi R., Nelson J.A., Ross C.A., Xing Y., Davidson B.L. Transcriptome-wide Discovery of microRNA Binding Sites in Human Brain. Neuron 2013.
8. Chang S.H., Hla T. Gene regulation by RNA binding proteins and microRNAs in angiogenesis. Trends Mol. Med. 2011, 17:650-658.
9. Chang S.H., Lu Y.C., Li X., Hsieh W.Y., Xiong Y., Ghosh M., Evans T., Elemento O., Hla T. Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis. J.Biol. Chem. 2013, 288:4908-4921.
10. Chekulaeva M., Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 2009, 21:452-460.
11. Chinchilla A., Lozano E., Daimi H., Esteban F.J., Crist C., Aranega A.E., Franco D. MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression. Cardiovasc. Res. 2011, 89:98-108.
12. Ciafrè S.A., Galardi S. microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer. RNA Biol. 2013, 10:935-942.
13. Corcoran D.L., Georgiev S., Mukherjee N., Gottwein E., Skalsky R.L., Keene J.D., Ohler U. PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol. 2011, 12:R79.
14. De Palma M., Lewis C.E. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013, 23:277-286.
15. Denkert C., Koch I., von Keyserlingk N., Noske A., Niesporek S., Dietel M., Weichert W. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod. Pathol. 2006, 19:1261-1269.
16. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
17. Fantin A., Vieira J.M., Plein A., Denti L., Fruttiger M., Pollard J.W., Ruhrberg C. NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood 2013, 121:2352-2362.
18. Farazi T.A., Spitzer J.I., Morozov P., Tuschl T. miRNAs in human cancer. J.Pathol. 2011, 223:102-115.
19. Ghosh M., Aguila H.L., Michaud J., Ai Y., Wu M.T., Hemmes A., Ristimaki A., Guo C., Furneaux H., Hla T. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J.Clin. Invest. 2009, 119:3530-3543.
20. Giannice R., Erreni M., Allavena P., Buscaglia M., Tozzi R. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study. Cytokine 2013, 64:509-515.
21. Gorospe M., Tominaga K., Wu X., Fähling M., Ivan M. Post-transcriptional control of the hypoxic response by RNA-binding proteins and MicroRNAs. Front. Mol. Neurosci 2011, 4:7.
22. Grande-García A., del Pozo M.A. Caveolin-1 in cell polarization and directional migration. Eur. J. Cell Biol. 2008, 87:641-647.
23. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Ascano M., Jungkamp A.C., Munschauer M., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
24. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Ascano M., Jungkamp A.C., Munschauer M., et al. PAR-CliP-a method to identify transcriptome-wide the binding sites of RNA binding proteins. J.Vis. Exp. 2010, 41:2580-2596.
25. Huang W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
26. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
27. Humtsoe J.O., Liu M., Malik A.B., Wary K.K. Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures. Mol. Cell. Biol. 2010, 30:1593-1606.
28. Katsanou V., Milatos S., Yiakouvaki A., Sgantzis N., Kotsoni A., Alexiou M., Harokopos V., Aidinis V., Hemberger M., Kontoyiannis D.L. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol. Cell. Biol. 2009, 29:2762-2776.
29. Kedde M., Strasser M.J., Boldajipour B., Oude Vrielink J.A., Slanchev K., le Sage C., Nagel R., Voorhoeve P.M., van Duijse J., Ørom U.A., et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 2007, 131:1273-1286.
30. Kedde M., van Kouwenhove M., Zwart W., Oude Vrielink J.A., Elkon R., Agami R. A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility. Nat. Cell Biol. 2010, 12:1014-1020.
31. Keene J.D. RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 2007, 8:533-543.
32. Kim H.H., Kuwano Y., Srikantan S., Lee E.K., Martindale J.L., Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 2009, 23:1743-1748.
33. Koide N., Odkhuu E., Naiki Y., Tsolmongyn B., Ito K., Komatsu T., Yoshida T., Yokochi T. Augmentation of LPS-induced vascular endothelial cell growth factor production in macrophages by transforming growth factor-beta1. Innate Immun. 2013, 20:816-825.
34. Lebedeva S., Jens M., Theil K., Schwanhäusser B., Selbach M., Landthaler M., Rajewsky N. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol. Cell 2011, 43:340-352.
35. Leung A.K., Young A.G., Bhutkar A., Zheng G.X., Bosson A.D., Nielsen C.B., Sharp P.A. Genome-wide identification of Ago2 binding sites from mouse embryonic stem cells with and without mature microRNAs. Nat. Struct. Mol. Biol. 2011, 18:237-244.
36. Levadoux-Martin M., Gouble A., Jégou B., Vallet-Erdtmann V., Auriol J., Mercier P., Morello D. Impaired gametogenesis in mice that overexpress the RNA-binding protein HuR. EMBO Rep. 2003, 4:394-399.
37. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
38. Lue H., Dewor M., Leng L., Bucala R., Bernhagen J. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell. Signal. 2011, 23:135-144.
39. Mai A., Veltel S., Pellinen T., Padzik A., Coffey E., Marjomäki V., Ivaska J. Competitive binding of Rab21 and p120RasGAP to integrins regulates receptor traffic and migration. J.Cell Biol. 2011, 194:291-306.
40. Mao J., Wang D., Mataleena P., He B., Niu D., Katayama K., Xu X., Ojala J.R., Wang W., Shu Q., et al. Myo1e impairment results in actin reorganization, podocyte dysfunction, and proteinuria in zebrafish and cultured podocytes. PLoS ONE 2013, 8:e72750.
41. Mukherjee N., Corcoran D.L., Nusbaum J.D., Reid D.W., Georgiev S., Hafner M., Ascano M., Tuschl T., Ohler U., Keene J.D. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol. Cell 2011, 43:327-339.
42. Rasheed S.A., Teo C.R., Beillard E.J., Voorhoeve P.M., Casey P.J. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. J.Biol. Chem. 2013, 288:7986-7995.
43. Rounbehler R.J., Fallahi M., Yang C., Steeves M.A., Li W., Doherty J.R., Schaub F.X., Sanduja S., Dixon D.A., Blackshear P.J., Cleveland J.L. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell 2012, 150:563-574.
44. Ruffell B., Affara N.I., Coussens L.M. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012, 33:119-126.
45. Saito Y., Suzuki H., Tsugawa H., Imaeda H., Matsuzaki J., Hirata K., Hosoe N., Nakamura M., Mukai M., Saito H., Hibi T. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS ONE 2012, 7:e47396.
46. Sonda N., Simonato F., Peranzoni E., Calì B., Bortoluzzi S., Bisognin A., Wang E., Marincola F.M., Naldini L., Gentner B., et al. miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity 2013, 38:1236-1249.
47. Valluru M., Staton C.A., Reed M.W., Brown N.J. Transforming Growth Factor-β and Endoglin Signaling Orchestrate Wound Healing. Front. Physiol. 2011, 2:89.
48. Vo D.T., Abdelmohsen K., Martindale J.L., Qiao M., Tominaga K., Burton T.L., Gelfond J.A., Brenner A.J., Patel V., Trageser D., et al. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells. Mol. Cancer Res. 2012, 10:143-155.
49. Wang J., Guo Y., Chu H., Guan Y., Bi J., Wang B. Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis. Int. J. Mol. Sci. 2013, 14:10015-10041.
50. Weijts B.G., Bakker W.J., Cornelissen P.W., Liang K.H., Schaftenaar F.H., Westendorp B., de Wolf C.A., Paciejewska M., Scheele C.L., Kent L., et al. E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1. EMBO J. 2012, 31:3871-3884.
51. Weischenfeldt J., Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008, 2008. 10.1101/pdb.prot5080.
52. Wheeler A.P., Ridley A.J. RhoB affects macrophage adhesion, integrin expression and migration. Exp. Cell Res. 2007, 313:3505-3516.
53. Yablonka-Reuveni Z., Rivera A.J. Influence of PDGF-BB on proliferation and transition through the MyoD-myogenin-MEF2A expression program during myogenesis in mouse C2 myoblasts. Growth Factors 1997, 15:1-27.
54. Yester J.W., Tizazu E., Harikumar K.B., Kordula T. Extracellular and intracellular sphingosine-1-phosphate in cancer. Cancer Metastasis Rev. 2011, 30:577-597.
55. Zhang J., Modi Y., Yarovinsky T., Yu J., Collinge M., Kyriakides T., Zhu Y., Sessa W.C., Pardi R., Bender J.R. Macrophage β2 integrin-mediated, HuR-dependent stabilization of angiogenic factor-encoding mRNAs in inflammatory angiogenesis. Am. J. Pathol. 2012, 180:1751-1760.